Incyte (INCY)
(Delayed Data from NSDQ)
$57.10 USD
+0.24 (0.42%)
Updated May 17, 2024 04:00 PM ET
After-Market: $57.14 +0.04 (0.07%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum D VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 35% (86 out of 249)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.10 | 1.35 | 9.99 |
Current Quarter Estimate | 1.14 | 7.43 | 57.00 |
Year Ago Quarter Estimate | 0.99 | 0.12 | 52.54 |
Next Quarter Estimate | 1.24 | 7.81 | 61.00 |
Next Year Estimate | 5.31 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 22.73 | 14.60 | 15.67 |
Next Year | 22.92 | 7.90 | 9.31 |
Last 5 Years | 16.80 | 1.00 | 8.10 |
Next 5 Years | 9.20 | 20.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 15.07 | -2.18 |
Price/Book (MRQ) | 2.38 | 2.10 |
Price/Cash Flow (MRFY) | 23.45 | 16.35 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 19.78% | -88.73% |
Return on Equity (TTM) | 12.83% | -44.24% |
Debt to Equity (MRQ) | 0.01 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.